Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist.
暂无分享，去创建一个
M. Dwyer | J. Baldwin | L. Ozgur | D. Rindgen | J. Fossetta | D. Lundell | Tara M Stauffer | J. Fine | A. Taveras | Cynthia J. Aki | J. Chao | V. Girijavallabhan | Tara M. Stauffer | B. Kaiser | J. Jakway | Hongzhu Bian | W. Gonsiorek | C. Terminelli | Jianhua Chao | L. Rokosz | Ge Li | Richard Bond | Xuedong Fan | Younong Yu | P. Biju | Rosemary Mayer-Ezel | J. Merritt | R. Hipkin | Wei Wang